AbCellera, a Vancouver-based biotechnology company listed on Nasdaq under the ticker ABCL, has announced that it will report its financial results for the third quarter of 2026. The scheduled date for this announcement is November 9, 2026. Following the release of the financial results, AbCellera will hold an earnings conference call at 3:00 p.m. Pacific Time, which translates to 5:00 p.m. Eastern Time. Shareholders and interested parties will have the opportunity to access a live audio webcast of the conference call, providing them with insights into the company’s performance during the third quarter. This event is part of AbCellera's ongoing efforts to communicate transparently with its stakeholders about its financial health and operational developments.
Analyzed Canadian Outlets (2)
1 headline · wire copies grouped